Dr. Raymond Chung is Director of Hepatology and the Liver Center, Vice Chief of Gastroenterology and the Kevin and Polly Maroni Research Scholar at Massachusetts General Hospital. He has been an internationally recognized researcher in the areas of HCV virology and pathogenesis. He directs an NIH Cooperative Center for Human Immunology centered on HCV, and is co-PI of the Harvard HBV Consortium of the NIH HBV Research Network. He is contact PI of the MGH GI Division’s T32 Training Grant, and holds several NIH R01 grants and an NIH K24 Mentorship Award.
He was recently Associate Editor of HEPATOLOGY and has previously served as a Councilor at Large for the AASLD. He is currently co-Chair of the AASLD/IDSA HCV Guidance panel which is charged with issuing treatment recommendations for hepatitis C. He has authored more than 300 original articles, reviews, and editorials.
Conflict of Interest
Dr. Raymond T. Chung has received grant support from Abbvie, Gilead, Merck, Janssen, Bristol-Myers Squibb, Roche, and Boehringer Ingelheim. He serves on the data safety monitoring board for Alnylam.